Screener
AnaptysBio, Inc. ANAB Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
FAQ
- What is AnaptysBio, Inc.'s shares (diluted)?
- AnaptysBio, Inc. (ANAB) reported shares (diluted) of 28.7M in Q1 2026.
- How has AnaptysBio, Inc.'s shares (diluted) changed year-over-year?
- AnaptysBio, Inc.'s shares (diluted) decreased by 6.4% year-over-year, from 30.6M to 28.7M.
- What is the long-term trend for AnaptysBio, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s shares (diluted) has grown at a 1.7% compound annual growth rate (CAGR), from 109.6M to 117.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about AnaptysBio, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude